Baillie Gifford Glenfinlas Global H
Latest (Mid) Price:
GBX 130.80
Day Change:
+1.40%
| Shares Class | Inc. |
|---|---|
| Yield | 2.00 |
| Total Expense Ratio | 0.00 |
Fund Performance
Cumulative Performance
Discrete Performance
MoneyAM Fund Centre
Quick Stats
| Fund Size | 0.00 | Launch Date | 24/09/2012 | Standard Initial Charge (%) | 0.00 |
|---|---|---|---|---|---|
| Currency | GBX | ISA Eligible | No | Annual Management Charge (%) | 0.00 |
| Sector | IMA UK Equity Income | Min Investment (£) | 250,000.00 | Total Expense Ratio (%) | 0.00 |
| ISIN | GB00B8JXYN62 | Min Topup (£) | 0.00 | Ongoing Charge (%) | 0.2000 (on 31/01/2013) |
Fund Objective
The objective is to achieve capital growth over the longer term. Investment will principally be in shares issued by companies located throughout the world involved in: the design and development; manufacture; and/or sale of products and services used in healthcare, medicine and/or biotechnology industries. The Fund may from time to time have exposure to some small and medium sized companies but it may invest in any size of company. The Fund may also hold cash, near cash and deposits.
Asset Breakdown
Region Breakdown
Sector Breakdown
Top 10 Holdings
Please remember that past performance is not a guide of future returns. The value of investments and the income from them can go down as well as up as a result of currency exchange and market fluctuations and investors may not get back the amount originally invested.
Fund data supplied by
